An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy
Public ClinicalTrials.gov record NCT05055024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Study identification
- NCT ID
- NCT05055024
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NLS Pharmaceutics
- Industry
- Enrollment
- 52 participants
Conditions and interventions
Interventions
- Mazindol Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2021
- Primary completion
- Jan 18, 2023
- Completion
- Jan 18, 2023
- Last update posted
- Mar 12, 2023
2021 – 2023
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sleep Disorders Center of Alabama | Birmingham | Alabama | 35213 | — |
| Stanford Sleep Medicine Center | Redwood City | California | 94063 | — |
| Pacific Research Network | San Diego | California | 92103 | — |
| St. Francis Sleep Allergy and Lung Institute | Clearwater | Florida | 33765 | — |
| Sleep Medicine Specialists of South Florida | Miami | Florida | 33126 | — |
| Ivetmar Medical Group | Miami | Florida | 33155 | — |
| The Angel Medical Research Corporation | Miami Lakes | Florida | 33016 | — |
| Treken Primary care | Atlanta | Georgia | 30315 | — |
| NeuroTrials Research | Atlanta | Georgia | 30328 | — |
| Clinical Research Institute | Stockbridge | Georgia | 30281 | — |
| Hawaii Pacific Neuroscience Clinical Research Center | Honolulu | Hawaii | 96817 | — |
| The Center For Sleep & Wake Disorders | Chevy Chase | Maryland | 20815 | — |
| Sleep and Attention Disorders | Sterling Heights | Michigan | 48314 | — |
| Neurology and Sleep Disorders Clinic | Columbia | Missouri | 65212 | — |
| Carolinas Sleep Specialists | Concord | North Carolina | 28025 | — |
| Superior Clinical Research, LLC | Goldsboro | North Carolina | 27534 | — |
| Advanced Respiratory and Sleep Medicine | Huntersville | North Carolina | 28078 | — |
| Intrepid Research | Cincinnati | Ohio | 45245 | — |
| Ohio Sleep Medicine Institute | Dublin | Ohio | 43017 | — |
| Bogan Sleep Consultants | Columbia | South Carolina | 29201 | — |
| Dharma PA d/b/a Southwest Family Medicine Associates | Dallas | Texas | 75235 | — |
| Sleep Therapy & Research Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05055024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05055024 live on ClinicalTrials.gov.